Fig. 3From: CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapyHomotypic target and immune escape capacity of UCNPs-Cas9@CM. A CLSM images and flow cytometry profiles of RAW264.7 cells upon 6 h of co-culture with UCNPs-Cas9 or UCNPs-Cas9@CM. B CLSM images and flow cytometry profiles of HepG2.2.15, HEK293T, Hela, L929 cells after 6 h of co-culture with UCNPs-Cas9@CM2.2.15. Scale bars: 25 μmBack to article page